- Home
- ESP vs CCCC Comparison
ESP vs CCCC Comparison
Compare ESP & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESP
- CCCC
- Stock Information
- Founded
- ESP 1928
- CCCC 2015
- Country
- ESP United States
- CCCC United States
- Employees
- ESP N/A
- CCCC N/A
- Industry
- ESP Industrial Machinery/Components
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- ESP Technology
- CCCC Health Care
- Exchange
- ESP Nasdaq
- CCCC Nasdaq
- Market Cap
- ESP 148.8M
- CCCC 175.1M
- IPO Year
- ESP N/A
- CCCC 2020
- Fundamental
- Price
- ESP $38.29
- CCCC $2.29
- Analyst Decision
- ESP
- CCCC Strong Buy
- Analyst Count
- ESP 0
- CCCC 4
- Target Price
- ESP N/A
- CCCC $8.50
- AVG Volume (30 Days)
- ESP 49.1K
- CCCC 2.4M
- Earning Date
- ESP 11-12-2025
- CCCC 10-30-2025
- Dividend Yield
- ESP 2.63%
- CCCC N/A
- EPS Growth
- ESP 31.88
- CCCC N/A
- EPS
- ESP 3.02
- CCCC N/A
- Revenue
- ESP $43,950,872.00
- CCCC $34,240,000.00
- Revenue This Year
- ESP N/A
- CCCC N/A
- Revenue Next Year
- ESP N/A
- CCCC N/A
- P/E Ratio
- ESP $12.91
- CCCC N/A
- Revenue Growth
- ESP 13.46
- CCCC 16.55
- 52 Week Low
- ESP $24.85
- CCCC $1.09
- 52 Week High
- ESP $55.00
- CCCC $7.14
- Technical
- Relative Strength Index (RSI)
- ESP 33.40
- CCCC 41.86
- Support Level
- ESP $36.76
- CCCC $2.09
- Resistance Level
- ESP $40.06
- CCCC $2.33
- Average True Range (ATR)
- ESP 2.68
- CCCC 0.24
- MACD
- ESP -0.56
- CCCC -0.07
- Stochastic Oscillator
- ESP 11.72
- CCCC 12.75
About ESP Espey Mfg. & Electronics Corp.
Espey Manufacturing & Electronics Corp designs, develops, tests, and manufactures specialized military and rugged industrial power supplies and transformers for use in harsh or severe environment applications. Its products and solutions include power converters, power conditioning, high-voltage radar, contract manufacturing, custom engineering, and others. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.